17,925 Shares in Cardinal Health, Inc. (NYSE:CAH) Acquired by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. acquired a new stake in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 17,925 shares of the company’s stock, valued at approximately $1,981,000.

A number of other institutional investors have also recently bought and sold shares of the business. Global X Japan Co. Ltd. boosted its position in shares of Cardinal Health by 6.3% in the 3rd quarter. Global X Japan Co. Ltd. now owns 4,362 shares of the company’s stock worth $482,000 after purchasing an additional 258 shares during the last quarter. Eastern Bank acquired a new position in Cardinal Health in the third quarter valued at about $25,000. Signaturefd LLC boosted its holdings in Cardinal Health by 18.7% during the third quarter. Signaturefd LLC now owns 2,701 shares of the company’s stock worth $298,000 after buying an additional 425 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Cardinal Health by 39.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 7,670 shares of the company’s stock worth $848,000 after buying an additional 2,178 shares during the period. Finally, Carolina Wealth Advisors LLC bought a new stake in shares of Cardinal Health in the 3rd quarter valued at about $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $112.23 on Wednesday. Cardinal Health, Inc. has a 52 week low of $90.19 and a 52 week high of $116.05. The stock’s 50 day moving average price is $111.42 and its two-hundred day moving average price is $103.94. The stock has a market capitalization of $27.34 billion, a price-to-earnings ratio of 49.88, a PEG ratio of 1.57 and a beta of 0.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. The business had revenue of $59.87 billion for the quarter, compared to analyst estimates of $58.74 billion. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The firm’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.55 earnings per share. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were issued a $0.506 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.80%. Cardinal Health’s dividend payout ratio (DPR) is presently 89.78%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CAH shares. UBS Group lifted their price objective on shares of Cardinal Health from $125.00 to $134.00 and gave the stock a “buy” rating in a research note on Tuesday. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 17th. Wells Fargo & Company raised their price objective on Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research note on Thursday, August 15th. Deutsche Bank Aktiengesellschaft boosted their target price on Cardinal Health from $115.00 to $119.00 and gave the company a “hold” rating in a research note on Friday, August 16th. Finally, Argus increased their price target on Cardinal Health from $115.00 to $125.00 and gave the stock a “buy” rating in a report on Wednesday, September 11th. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $120.18.

Insider Activity at Cardinal Health

In related news, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the completion of the transaction, the insider now directly owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, insider Michelle D. Greene sold 4,000 shares of the business’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $108.85, for a total transaction of $435,400.00. Following the transaction, the insider now directly owns 19,242 shares in the company, valued at approximately $2,094,491.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 16,573 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the completion of the sale, the insider now owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 113,963 shares of company stock valued at $12,379,980. 0.15% of the stock is owned by insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.